News

Tandem Diabetes Care, Inc.’s TNDM impressive international expansion is expected to bolster growth in the upcoming quarters. A robust diabetes market provides a favorable opportunity for the company’s ...
RBC Capital lowered the firm’s price target on Tandem Diabetes (TNDM) to $45 from $55 and keeps an Outperform rating on the shares as part of a ...
The two men were golfing in Florida on Saturday. More from Trump’s interview with NBC News: The president said he “couldn’t care less” if automakers raised prices after he announced he ...
Mizuho initiated coverage of Tandem Diabetes (TNDM) with a Neutral rating and $20 price target The firm’s neutral stance reflects both the ...
Pharmaceuticals, which accounted for $200 billion in U.S. imports in 2024, are exempt from the 10% global tariff. Diabetes device makers face tariff-related pressures, while larger cardiac and ...
2. Diagnosis and classification of diabetes: standards of care in diabetes—2025. Diabetes Care. 2025;48(Supplement_1):S27-S49. doi:10.2337/dc25-S002 Sheng Z, Cao JY, Pang YC, et al. Effects of ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
President Donald Trump said he “couldn’t care less” if international automakers increase pricing due to his 25% tariffs on all foreign-made auto parts and imported vehicles announced several ...
You can discuss your diabetes management and care plan with your healthcare team, letting them know if a particular medication or care plan isn’t working as well as you’d like. This can help ...
These stocks offer a middle ground with... Tandem Diabetes Care, Inc. (NASDAQ:TNDM) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate ...